Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Intervirology

Showing results (301-310 of 2,582) with videos related to

Pageof 259
Sort By:
Intervirology|January 1, 1975
Selective solubilization of hemagglutinin and neuraminidase from influenza virusesH Bachmayer
Intervirology|February 5, 2003
Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapyNahoko Okamoto, Hiroshi Yotsuyanagi, Seido Ooka, et al.
Intervirology|February 5, 2003
Genetic characterization of a porcine H1N2 influenza virus strain isolated in GermanyChristine Schrader, Jochen Süss
Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
Intervirology|February 5, 2003
Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infectionStephan Menne, Carol A Roneker, Bud C Tennant, et al.
Intervirology|February 5, 2003
Vaccine development using the simian immunodeficiency virus model for AIDSStephen Norley, Brigitte Beer, Doris Binninger-Schinzel, et al.
Intervirology|February 5, 2003
A short introduction to papillomavirus biologyRolf E Streeck
Intervirology|February 27, 2003
A malaria vaccine candidate based on a hepatitis B virus core platformMatti Sällberg, Janice Hughes, Joyce Jones, et al.
Intervirology|February 27, 2003
RNA bacteriophage capsid-mediated drug delivery and epitope presentationWilliam L Brown, Robert A Mastico, Min Wu, et al.
Intervirology|January 24, 2002
Inhibition of Mayaro virus replication by prostaglandin A(1) in Vero cellsF M Burlandy, M A Rebello
Pageof 259

Showing results (301-310 of 2,582) with videos related to

Sort By:
Pageof 259
Intervirology|January 1, 1975
Selective solubilization of hemagglutinin and neuraminidase from influenza virusesH Bachmayer
Intervirology|February 5, 2003
Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapyNahoko Okamoto, Hiroshi Yotsuyanagi, Seido Ooka, et al.
Intervirology|February 5, 2003
Genetic characterization of a porcine H1N2 influenza virus strain isolated in GermanyChristine Schrader, Jochen Süss
Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
Intervirology|February 5, 2003
Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infectionStephan Menne, Carol A Roneker, Bud C Tennant, et al.
Intervirology|February 5, 2003
Vaccine development using the simian immunodeficiency virus model for AIDSStephen Norley, Brigitte Beer, Doris Binninger-Schinzel, et al.
Intervirology|February 5, 2003
A short introduction to papillomavirus biologyRolf E Streeck
Intervirology|February 27, 2003
A malaria vaccine candidate based on a hepatitis B virus core platformMatti Sällberg, Janice Hughes, Joyce Jones, et al.
Intervirology|February 27, 2003
RNA bacteriophage capsid-mediated drug delivery and epitope presentationWilliam L Brown, Robert A Mastico, Min Wu, et al.
Intervirology|January 24, 2002
Inhibition of Mayaro virus replication by prostaglandin A(1) in Vero cellsF M Burlandy, M A Rebello
Pageof 259